Cellular Therapy Essentials: An Overview of Cellular Therapy Products and Nursing Management
Clinical Journal of Oncology Nursing · 01.08.2026
DOI: 10.1188/26.cjon.309-313 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Journal of Oncology Nursing, online erschienen am 03.08.2026. Verfasst von Christi Bell. Beteiligte Einrichtung: Christi Bell. Hauptthemen laut MEDLINE: Cell- and Tissue-Based Therapy, Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cellular therapy is a rapidly evolving modality affecting oncology and non-oncology disease states. This article addresses several cellular therapies. First, chimeric antigen receptor (CAR) T-cell therapy has expanded to include indications for second- and third-line treatment of patients with diffuse large B-cell lymphoma, follicular and mantle cell lymphomas, adult and pediatric acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma. Next, tumor-infiltrating lymphocyte (TIL) cell therapy is indicated for second-line metastatic malignant melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Christi Bell.
Zitieren
APA
Bell, C. (2026). Cellular Therapy Essentials: An Overview of Cellular Therapy Products and Nursing Management. Clinical Journal of Oncology Nursing. https://doi.org/10.1188/26.cjon.309-313
Vancouver
Bell C. Cellular Therapy Essentials: An Overview of Cellular Therapy Products and Nursing Management. Clinical Journal of Oncology Nursing. 2026. doi:10.1188/26.cjon.309-313
BibTeX
@article{Bell2026,
author = {Bell, Christi},
title = {Cellular Therapy Essentials: An Overview of Cellular Therapy Products and Nursing Management},
journal = {Clinical Journal of Oncology Nursing},
year = {2026},
doi = {10.1188/26.cjon.309-313}
}
EUVIMED